would it be fair to say guys that we could see an sp of 40/45 in these cuurent market conditions with the agreement signed off and announced.. what are your thoughts.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%